Christian Carlos. Pen 360 Press [P360P].
The government of Mexico announced this morning the vaccination plan that will be carried out in the country to confront the COVID-19 pandemic. The announcement was made by the country's deputy minister of health, Hugo L ez-Gatell.
The vaccine will be universally accessible and free, meaning it covers the entire population in the country.
It will begin in the City of Mico and in the state of Coahuila, Mico with health professionals who are caring for patients with COVID-19.
The vaccination campaign is expected to begin in the third week of December with vaccines from CanSino Biologics, of Chinese origin with an effectiveness of 97%; the American vaccine Pfizer-BioNTech, with a reported effectiveness of 95%; and, the Oxford-AstraZeneca vaccine, of European origin with 90% of effectiveness against the SARS-CoV-2 virus.
The president of Mexico, Andr Manuel L ez Obrador, announced that the funds for the vaccination plan are ready, specifically 20 billion pesos, for the acquisition of 34 million doses of the Pfizer-BioNTech vaccine; 77 million doses of the Oxford-AstraZeneca vaccine and 35 million doses of the CanSino vaccine.
L ez-Gatell said that the objective is to reach 75% of the population over 16 years old and it was announced that there will be 7 stages in which the vaccination plan will be divided, which includes its distribution by age groups:
- Health workers. In December 2020 and February 2021.
- People aged 80 and over. Before February 2021.
- People between 70 and 79 years old. Before February 2021.
- People between 60 and 69 years old. In February and April 2021.
- People between 50 and 59 years old. In April and May 2021.
- People between 40 and 49 years old. In May and June 2021.
- Population under 40 years old. From June 2021 and before March 2022.
The Foreign Minister of Mexico, Marcelo Luis Ebrard Casaub, said that early access to vaccines was also due to the early integration into COVAX, which, according to the World Health Organization (WHO), said its objective is